New statistical tools can help decide how to allocate resources to the patients who need them the most
AMHERST, Mass. – One of the major problems that has slowed progress toward universal access to life-saving antiretroviral therapy (ART) to treat AIDS in developing nations has been limited availability of laboratories and trained medical staff to conduct blood tests of immune system CD-4 T-cell levels that indicate when to start ART. Read More







